Dishman Carbogen Amcis opens $50 million new facility in France

Built on newly acquired land located 7km from an existing CARBOGEN AMCIS site in Riom, the new facility increases product development and manufacturing capacity for liquid and freeze-dried products for pre-clinical and clinical trials as well as small scale commercial use, the company said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Csnw0x9
via IFTTT